MARC S BERRIDGE
Pilots at Shadowbrook Dr, Cleveland, OH

License number
Ohio A5175765
Issued Date
Apr 2016
Expiration Date
Apr 2018
Category
Airmen
Type
Authorized Aircraft Instructor
Address
Address
32600 Shadowbrook Dr, Cleveland, OH 44139

Personal information

See more information about MARC S BERRIDGE at radaris.com
Name
Address
Phone
Marc Berridge, age 70
32600 Shadowbrook Dr, Solon, OH 44139
(440) 349-3910
Marc Berridge
Chagrin Falls, OH
(440) 349-3910
Marc S Berridge, age 70
32600 Shadowbrook Dr, Solon, OH 44139
(440) 349-3910

Professional information

Marc Berridge Photo 1

Process And Apparatus For Synthesizing Oxygen-15 Labelled Butanol For Positron Emission Tomography

US Patent:
5082980, Jan 21, 1992
Filed:
Jun 13, 1990
Appl. No.:
7/537312
Inventors:
Marc S. Berridge - Solon OH
Assignee:
Case Western Reserve University - Cleveland OH
International Classification:
C07C 2909, C07C 2976, C07C 3112
US Classification:
568917
Abstract:
The present invention is directed to a process and apparatus for synthetically producing. sup. 15 O-labeled butanol for position emission tomography. A procedure and apparatus have been developed for the routine rapid and sequential synthesis of oxygen-15 labeled butanol in the amounts and with the purity suitable for use in clinical position tomography. This procedure can replace oxygen-15 labeled water which is more commonly used for routine application, as well as the prior art processes for producing oxygen-15 labeled butanol.


Marc Berridge Photo 2

Radiolabeled Solid Surfaces And Process For Making Them

US Patent:
2003015, Aug 21, 2003
Filed:
Jan 11, 2002
Appl. No.:
10/043491
Inventors:
Chaim Sukenik - D.N. Shimshon, IL
Harold Jacob - Cedarhurst NY, US
Marc Berridge - Solon OH, US
International Classification:
A61N005/00, A61F002/06, A61L002/00
US Classification:
600/001000, 623/001440, 427/002240
Abstract:
A device, which comprises a surface layer that has incorporated therein at least one radioactive nuclide. The surface layer is a self-assembled layer, particularly an anchored SAM that is selected from the group consisting of monolayers or films anchored by siloxane, thiol, amine or phosphonate. The surface layer may be formed of a radioactive material that has been activated to induce radioactivity therein after its final formation. The device may comprise a chemically functionalized SAM incorporating radionuclides attached at the surface of the device. The device may be a temporary or permanent therapeutic implant, such as a stent.